Medtronic China ventures (MCV) was initiated and founded by Medtronic and Sequoia in 2016. MCV invests in med-tech and services startups and accelerates oversea technologies to China.

• ‪Identify investment opportunities that address ‪disease centric unmet needs
• Breakdown boundaries of medical technology innovation in global landscape
• Ÿ‪Accelerate innovation from product development to market adoption
• Ÿ‪Cultivate ecosystem by building ‪alliances ‪with key stakeholders

MCV is positioned as the investor and partner of choice for medtech start ups. We build deep knowledge and global network to identify leading technologies and teams. We form partnership with our portfolio to leverage resources and operating platform to accelerate innovation and unlock value.